dalteparin and per977

dalteparin has been researched along with per977 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ansell, JE	1
Eikelboom, JW; Weitz, JI	1

Reviews

1 review(s) available for dalteparin and per977

Article	Year
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:3 Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Arginine; Blood Coagulation Disorders; Blood Coagulation Factors; Coagulants; Combined Modality Therapy; Dabigatran; Drugs, Investigational; Enoxaparin; Factor Xa; Fibrinolytic Agents; Humans; Piperazines; Practice Guidelines as Topic; Recombinant Proteins; Vitamin K	2016

Article

Year

Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:3

Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Arginine; Blood Coagulation Disorders; Blood Coagulation Factors; Coagulants; Combined Modality Therapy; Dabigatran; Drugs, Investigational; Enoxaparin; Factor Xa; Fibrinolytic Agents; Humans; Piperazines; Practice Guidelines as Topic; Recombinant Proteins; Vitamin K

2016

Other Studies

1 other study(ies) available for dalteparin and per977

Article	Year
Ciraparantag for enoxaparin reversal: Adding to the evidence. Thrombosis research, 2016, Volume: 146 Topics: Arginine; Enoxaparin; Humans; Piperazines	2016